TIL-expressing TIM-3 should be induced in response to immunologic pressure, which explains why their presence is associated with prolonged survival and emerges as a pivotal marker to guide immunotherapeutic candidates of GIST. This evidence concerns the gene HAVCR2 and gastrointestinal stromal tumor.